Mandate

Vinge advises the founders of Future Media Group in conjunction with the sale to Caybon

Vinge has advised the founders Rikard Virta, Linus Wennerström and Johan Oscarsson as well as the other shareholders in conjunction with the sale of Future Media Group AB to Caybon.

Future Media Group specialises in helping media owners and growth companies to generate new revenue streams through business development, product development and sales. In close co-operation with its partners, new advertising formats, media solutions and marketing concepts are developed, and the solutions to the correct target groups are prepared in conjunction with the different sales organisations specialising in different types of products and customer segments.

Future Media Groups current partners currently include large media groups such as Bonnier and Stampen, as well as niche actors such as Preglife (the Nordic Region’s leading pregnancy app) and the digital veterinary service, Firstvet. The company has offices in Stockholm and Oslo and employs approximately 100 persons. 

Vinges team has primarily consisted of Jonas JohanssonCarl SanderEllinor Wargenbrant and Linus Adolfsson (M&A), as well as Sara Dahlros Sköld and Ellinore Boström Andersson (VDR).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025